STAT+: Minnesota report shows large hospitals continue to dominate the 340B drug discount program
Minnesota hospitals and clinics participating in a controversial U.S. drug discount program reaped at least $1.34 billion in revenue in 2024.
Health
STAT+: Trump most-favored nation drug pricing deals end after three years for some companies
SEC filings show that, at least for some drugmakers, "most-favored nation" drug pricing deals with President Trump last three years.
High-fiber diet linked to reduced risk of heart disease in night shift workers: Study
People who work at night have a higher risk of coronary artery disease, a type of heart disease. A new study suggests that a higher fibre intake in the diet…
Poly-L-lysine–Coated Catheters: Effective and Safe for Prevention of Catheter-Associated UTI: Study
Researchers have found in a new study that Poly-L-lysine (PLL)–coated urinary catheters are safe, well-tolerated, and noninferior to noble metal alloy (NMA)–coated catheters in preventing bacteriuria among adults requiring short-term…
Fremanezumab Reduces Migraine Days in Children and Adolescents: NEJM
A new study published in The New England Journal of Medicine showed that Fremanezumab reduced migraine and headache days more than a placebo in children and adolescents with episodic migraine.…
MMF-Based Regimen Shows Potential as Treatment Option for juvenile dermatomyositis: JAMA
A new study published in the Journal of the American Medical Association showed that for juvenile dermatomyositis (JDM), a combination of intermittent intravenous methylprednisolone pulse and mycophenolate mofetil (MMF) may…
MAJESTY Phase 3 Trial: Obinutuzumab shows positive efficacy and safety outcomes in Primary Membranous Nephropathy
The MAJESTY global phase 3 study evaluating obinutuzumab (Gazyva) in primary membranous nephropathy (PMN) demonstrated positive efficacy and safety outcomes. The trial successfully met its primary endpoint, with patients achieving…
Long-Term Opioid Therapy Linked to Increased Risk of Infection-Related Dental Complications: Study
USA: Researchers have found in a recent study that long-term opioid therapy (LTOT) is associated with a modestly increased risk of dental infections. The association, reported in PLOS One, suggests…
Cardiovascular Medicine 2025: Landmark Dyslipidaemia Studies Redefine Lipid Management
Turkey: The year 2025 marked a turning point in dyslipidaemia research, with major advances reshaping how lipid-related cardiovascular risk is understood and managed. In a viewpoint published in the European…
Majority of Baby Foods Classified as Ultra-Processed, Study Suggests
USA: A new study published in the MDPI journal Nutrients has raised concerns about the extent of ultra-processing in commercially available complementary foods for infants and toddlers in the United…